TELA Bio (TELA) Shares Outstanding (Weighted Average) (2018 - 2026)

TELA Bio has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $14.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 149.83% year-over-year to $14.7 million; the trailing twelve-month figure through Mar 2026 stood at $14.7 million (up 149.83% YoY), and the FY2025 full-year result was $46.9 million, up 697.27% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $14.7 million, roughly flat from $14.7 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $45.4 million in Q2 2025, with the low at $88556.0 in Q1 2022.
• Average Shares Outstanding (Weighted Average) over 5 years is $17.7 million, with a median of $15.3 million recorded in 2022.
• Year-over-year, Shares Outstanding (Weighted Average) sank 99.42% in 2023 and surged 27796.0% in 2024.
• Tracing TELA's Shares Outstanding (Weighted Average) over 5 years: stood at $88556.0 in 2022, then surged by 25723.96% to $22.9 million in 2023, then sank by 74.25% to $5.9 million in 2024, then surged by 149.83% to $14.7 million in 2025, then changed by 0.0% to $14.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $14.7 million (Q1 2026), $14.7 million (Q4 2025), and $45.4 million (Q3 2025), per Business Quant data.

Peer Comparison